The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection (CROSBI ID 192037)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Duplancic, Darko ; Cesarik, Marijan ; Poljak, Nikola Kolja ; Radman, Maja ; Kovacic, Vedran ; Radic, Josipa ; Rogosic Veljko
engleski
The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection
The ubiquitous distribution of vitamin D receptors in the human body is responsible for the pleiotropic effects of vitamin D-receptor activation. We discuss the possible beneficial effects of a selective activator of vitamin D receptor, paricalcitol, on the cardiovascular system in chronic heart failure patients and chronic kidney patients, in light of new trials. Paricalcitol should provide additional clinical benefits over the standard treatment for chronic kidney and heart failure, especially in cases of cardiorenal syndrome.
vitamin D deficiency ; cardiovascular system ; albuminuria ; inflammation
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti